Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Beroni Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $1.66 Mil. Beroni Group's Total Assets for the quarter that ended in Jun. 2024 was $5.64 Mil.
Therefore, Beroni Group's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.30.
The historical rank and industry rank for Beroni Group's Equity-to-Asset or its related term are showing as below:
BNIGF's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.6 * Ranked among companies with meaningful Equity-to-Asset only.
Beroni Group (OTCPK:BNIGF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Beroni Group Equity-to-Asset Related Terms
Beroni Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Beroni Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BNIGF vs PNXP, CRYM, GCAN: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beroni Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beroni Group Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beroni Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Beroni Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Beroni Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beroni Group (BNIGF) has a Equity-to-Asset of 0.30 as of Jun. 2024. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Beroni Group and its competitors.
Is Beroni Group's Equity-to-Asset too high?
Beroni Group's current Equity-to-Asset is 0.30. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Beroni Group's value of 0.30 is 50% below this industry median. Overall, Beroni Group has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Beroni Group's Equity-to-Asset compare to PNXP and CRYM?
Beroni Group's Equity-to-Asset of 0.30 can be compared against companies in the Drug Manufacturers industry. The industry median Equity-to-Asset is 0.60. Beroni Group's value of 0.30 is 50% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beroni Group's current Equity-to-Asset of 0.30 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Beroni Group and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beroni Group's current Equity-to-Asset is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beroni Group stock overvalued right now?
Beroni Group (BNIGF) has a current Equity-to-Asset of 0.30. The current Equity-to-Asset is 0.30 and 50% below the Drug Manufacturers industry median of 0.60. Beroni Group's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Beroni Group (BNIGF), the current Equity-to-Asset is 0.30 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beroni Group Ltd is an Australia based company engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Geographically, the company operates in China.
4GF Score
Get the complete analysis for BNIGF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BNIGF has been successfully added to your 
